| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M103106200 |
| P8608 | Fatcat ID | release_mx4dzloykjdghejpt7dmhshhe4 |
| P3181 | OpenCitations bibliographic resource ID | 232303 |
| P698 | PubMed publication ID | 11390394 |
| P50 | author | Ingrid De Meester | Q62670225 |
| Anne-Marie Lambeir | Q41790695 | ||
| Paul Proost | Q54449101 | ||
| Christine Durinx | Q59491456 | ||
| P2093 | author name string | Van Damme J | |
| Scharpé S | |||
| Bal G | |||
| Augustyns K | |||
| Senten K | |||
| P2860 | cites work | Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms | Q22009107 |
| Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3) | Q22009509 | ||
| Inhibition of HIV-1 infection by the beta-chemokine MDC | Q24309584 | ||
| Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants | Q27618367 | ||
| Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue | Q27627477 | ||
| Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type | Q27729420 | ||
| Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation | Q27765156 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity | Q28199341 | ||
| Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo | Q28203975 | ||
| Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblasts | Q28270212 | ||
| Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction | Q28296438 | ||
| Chemokines: a new classification system and their role in immunity | Q29615663 | ||
| Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease | Q29616432 | ||
| Chemokines and leukocyte traffic | Q29618886 | ||
| Metabolism of glucagon by dipeptidyl peptidase IV (CD26). | Q30976346 | ||
| Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. | Q32025761 | ||
| Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes | Q32159654 | ||
| CD26, let it cut or cut it down. | Q33702158 | ||
| Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides | Q33788748 | ||
| Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands | Q34118741 | ||
| The role of chemokines in human immunodeficiency virus infection | Q34118829 | ||
| Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis | Q34118839 | ||
| Lymphocyte traffic control by chemokines | Q34139610 | ||
| Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. | Q34447967 | ||
| Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages | Q36340560 | ||
| Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage | Q36380925 | ||
| The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine | Q36736256 | ||
| Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. | Q37400834 | ||
| Molecular analysis of CD26-mediated signal transduction in T cells | Q39091438 | ||
| Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV. | Q39318764 | ||
| Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. | Q39369861 | ||
| Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha | Q39369867 | ||
| CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. | Q39438516 | ||
| Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. | Q39494558 | ||
| Proline-dependent structural and biological properties of peptides and proteins | Q40881554 | ||
| The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth | Q44112317 | ||
| A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma | Q57975973 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 29839-29845 | |
| P577 | publication date | 2001-06-04 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family | |
| P478 | volume | 276 |
| Q34533162 | A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis |
| Q62660588 | A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro |
| Q36393859 | A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability |
| Q24795265 | A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy |
| Q28282265 | A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes |
| Q50063686 | Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria. |
| Q35102870 | Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior |
| Q34755199 | An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization |
| Q34516778 | Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche |
| Q34314564 | Apigenin and its impact on gastrointestinal cancers. |
| Q39432022 | Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. |
| Q47664682 | Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer |
| Q53162585 | CCR3 induced-p42/44 MAPK activation protects against staurosporine induced-DNA fragmentation but not apoptosis in airway smooth muscle cells. |
| Q38937243 | CD26 and Asthma: a Comprehensive Review. |
| Q92369079 | CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers |
| Q39816788 | CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion |
| Q35848800 | CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation |
| Q79223095 | CD26 is essential for normal G-CSF–induced progenitor cell mobilization as determined by CD26−/− mice |
| Q36319530 | CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1. |
| Q44909631 | CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12. |
| Q38690194 | CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology |
| Q38175452 | CD26: a key molecule in immune regulation and autoimmune diseases |
| Q39692148 | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. |
| Q91639548 | CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer? |
| Q33584855 | Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts |
| Q35613631 | Cell, isoform, and environment factors shape gradients and modulate chemotaxis |
| Q36274918 | Cell-surface enzymes in control of leukocyte trafficking |
| Q35818705 | Cell-surface peptidases |
| Q37349685 | Chemokine receptor antagonists: overcoming developmental hurdles |
| Q34942847 | Chemokines, chemokine receptors and small-molecule antagonists: recent developments |
| Q43185050 | Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling. |
| Q45148667 | Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells |
| Q37176935 | Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex. |
| Q30537598 | Convolution of chemoattractant secretion rate, source density, and receptor desensitization direct diverse migration patterns in leukocytes |
| Q34986499 | Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion |
| Q27642932 | Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation |
| Q26797335 | DPP4 in Diabetes |
| Q35107619 | DPPIV, seprase, and related serine peptidases in multiple cellular functions |
| Q58864235 | Development of potent and selective dipeptidyl peptidase II inhibitors |
| Q35723683 | Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells. |
| Q90233364 | Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice |
| Q37067760 | Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation |
| Q40652180 | Dipeptidyl peptidase IV (CD26) activity in the hematopoietic system: differences between the membrane-anchored and the released enzyme activity |
| Q35693453 | Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning |
| Q37130392 | Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent |
| Q36783164 | Dipeptidyl peptidase-4: a key player in chronic liver disease |
| Q35189265 | Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. |
| Q38863969 | Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy |
| Q53201799 | Discrimination of agonist and antagonist forms of CXCL10 in biological samples. |
| Q26782778 | Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives |
| Q36736740 | Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV) |
| Q36958353 | Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses |
| Q34626662 | Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis |
| Q85637773 | Enhancing hematopoietic growth factor performance |
| Q41356673 | Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. |
| Q35628959 | FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc |
| Q40370679 | Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line |
| Q42456034 | Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity. |
| Q40724468 | G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. |
| Q38681182 | Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling. |
| Q40109819 | Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology. |
| Q45152192 | Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice. |
| Q34074221 | Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain |
| Q33998570 | Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells |
| Q24670416 | Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation |
| Q35822337 | Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation |
| Q43162044 | Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts |
| Q34573849 | Investigation of the dimer interface and substrate specificity of prolyl dipeptidase DPP8. |
| Q27649728 | Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation |
| Q34100605 | Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion. |
| Q36403665 | Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency |
| Q52883482 | Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1). |
| Q36634172 | Multiple roles for chemokines in the pathogenesis of SIV infection |
| Q37641792 | Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo. |
| Q46630381 | Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells |
| Q24292941 | Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α |
| Q33327173 | Non-cell autonomous impairment of oligodendrocyte differentiation precedes CNS degeneration in the Zitter rat: implications of macrophage/microglial activation in the pathogenesis |
| Q24305361 | One site mutation disrupts dimer formation in human DPP-IV proteins |
| Q49524220 | Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. |
| Q57584127 | Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation and Anti-HIV-1 Activity |
| Q34270888 | Positional cloning of a novel gene influencing asthma from chromosome 2q14. |
| Q44016676 | Presence and release of SR-17 (chromogranin B(586-602)) in the porcine splenic nerve and its enzymatic degradation by CD26/dipeptidyl peptidase IV. |
| Q28216373 | Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity |
| Q35206949 | Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. |
| Q92224523 | Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation |
| Q36684219 | Regulation of CXCR4 signaling |
| Q28218749 | Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex |
| Q41862465 | Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. |
| Q60050332 | Regulation of heptaspanning-membrane-receptor function by dimerization and clustering |
| Q28237665 | Regulation of the immune response by the interaction of chemokines and proteases |
| Q34651364 | Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV. |
| Q33414625 | SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury |
| Q37204462 | Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum |
| Q33231553 | Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity |
| Q97527794 | Sierra: discovery of differential transcript usage from polyA-captured single-cell RNA-seq data |
| Q42030825 | Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1. |
| Q57294140 | Soluble Dipeptidyl Peptidase-4 Levels Are Associated with Decreased Renal Function in Patients with Type 2 Diabetes Mellitus |
| Q24313619 | Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8 |
| Q28243456 | Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha |
| Q39922341 | Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. |
| Q48009501 | Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. |
| Q28581602 | The 3D structure of rat DPPIV/CD26 as obtained by cryo-TEM and single particle analysis |
| Q57492022 | The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment |
| Q38623418 | The chemokine fractalkine (CX3CL1) attenuates H2O2-induced demyelination in cerebellar slices |
| Q34929196 | The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. |
| Q83380217 | The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells |
| Q37674999 | The dipeptidyl peptidase IV family in cancer and cell biology. |
| Q35041174 | The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes |
| Q45362053 | The long and the short of interferon-gamma-inducible protein 10 in hepatitis C virus infection. |
| Q33805518 | The regulatory role of DPP4 in atherosclerotic disease. |
| Q28215205 | The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity |
| Q44400093 | The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). |
| Q62019365 | The unique structural and functional features of CXCL12 |
| Q36040879 | Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs |
| Q34648201 | Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes |
| Q34652682 | Total body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation. |
Search more.